Gw Pharmaceuticals Plc. (PC) Stock Price - GWPRF

Best deals to access real time data!
SMALL CAP PRO
Monthly Subscription
for only
$43.59
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$59.99
SMALL CAP BASIC
Monthly Subscription
for only
$29.03
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Gw Pharmaceuticals Plc. (PC) GWPRF Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.85 -9.04% 8.55 9.4 8.5 9.396 9.4 16:26:08
Bid Price Ask Price Spread Spread % News
8.32 10.3 1.98 19.22% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
21 3,236 $ 9.0789 $ 29.38k 3.54k 6.67 - 11.53
Last Trade Time Type Quantity Stock Price Currency
14:28:36 16 $8.50 USD

Gw Pharmaceuticals Plc. (PC) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.12B 131.55M $ -63.66M - -17.67 -
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.01k 0.00% $ - 0.00% - -

more financials information »

Gw Pharmaceuticals Plc. (PC) News

Latest GWPRF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GWPRF Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week8.39.48.040.00001k8k4k0.253.01%
1 Month10.210.28.040.00001629k3k-1.65-16.18%
3 Months10.5411.118.040.00003115k3k-1.99-18.88%
6 Months9.911.288.040.00003124k4k-1.35-13.64%
1 Year7.4711.536.670.0000059k6k1.0814.46%
3 Years5.8311.5330.00000238k10k2.7246.66%
5 Years1.2511.530.580.00000273k15k7.3584.00%

Gw Pharmaceuticals Plc. (PC) Description

GW is a pharmaceutical group developing a portfolio of cannabinoid prescription medicines to meet patient needs in a wide range of therapeutic conditions. GW is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group's lead programme is the development of a product portfolio of cannabinoid prescription medicines , including Sativex Oromucosal Spray, to meet patient needs in a wide range of therapeutic indications
GW has assembled a large in-house team with extensive experience in developing cannabinoids, medicines containing controlled substances, as well as plant-based prescription pharmaceutical products. GW also holds GMP manufacturing licences for the manufacture of pharmaceutical products for both clinical trials and commercial purposes.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.